Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
29.24
+0.10 (0.34%)
At close: May 9, 2025, 4:00 PM
29.15
-0.09 (-0.31%)
After-hours: May 9, 2025, 4:08 PM EDT
Zai Lab Employees
Zai Lab had 1,869 employees as of December 31, 2024. The number of employees decreased by 306 or -14.07% compared to the previous year.
Employees
1,869
Change (1Y)
-306
Growth (1Y)
-14.07%
Revenue / Employee
$223,823
Profits / Employee
-$134,869
Market Cap
3.21B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZLAB News
- 1 day ago - Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
- 14 days ago - Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025 - Business Wire
- 16 days ago - Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting - Business Wire
- 18 days ago - Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors - Business Wire
- 6 weeks ago - Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - Business Wire
- 7 weeks ago - Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth - Seeking Alpha
- 7 weeks ago - Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks - Seeking Alpha
- 2 months ago - Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer - Business Wire